Nakamura, T., Bonnard, B., Palacios Ramírez, R., Fernández-Celis, A., Jaisser, F., & López-Andrés, N. (2022). Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury.
Citação norma ChicagoNakamura, Toshifumi, Benjamin Bonnard, Roberto Palacios Ramírez, Amaya Fernández-Celis, Frédéric Jaisser, y Natalia López-Andrés. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. 2022.
Citação norma MLANakamura, Toshifumi, et al. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.